LLY
1,108.92
+3.86%↑
JNJ
206.8
+0.38%↑
ABBV
231.86
+1.03%↑
UNH
326.26
+2.45%↑
AZN
93.26
+1.86%↑
LLY
1,108.92
+3.86%↑
JNJ
206.8
+0.38%↑
ABBV
231.86
+1.03%↑
UNH
326.26
+2.45%↑
AZN
93.26
+1.86%↑
LLY
1,108.92
+3.86%↑
JNJ
206.8
+0.38%↑
ABBV
231.86
+1.03%↑
UNH
326.26
+2.45%↑
AZN
93.26
+1.86%↑
LLY
1,108.92
+3.86%↑
JNJ
206.8
+0.38%↑
ABBV
231.86
+1.03%↑
UNH
326.26
+2.45%↑
AZN
93.26
+1.86%↑
LLY
1,108.92
+3.86%↑
JNJ
206.8
+0.38%↑
ABBV
231.86
+1.03%↑
UNH
326.26
+2.45%↑
AZN
93.26
+1.86%↑
24h
Atual
Mín
219.11
Máximo
220.03
Recomendações | Neutro |
|---|---|
Previsão para 12 meses | -4.8% downside |
By Trading Central
Confiança
Bearish Evidence
18.88 / 19.67 Suporte e Resistência
O desempenho passado não é um indicador confiável de resultados futuros.
14 de nov. de 2025, 12:31 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal -- Update
DJ
Ler
14 de nov. de 2025, 12:16 UTC
Merck to Buy Cidara Therapeutics in $9.2 Billion Deal
DJ
Ler
14 de nov. de 2025, 11:20 UTC
Cidara Shares Nearly Double Premarket on Report of Takeover by Merck
DJ
Ler
14 de nov. de 2025, 11:11 UTC
Merck Nears $9.2 Billion Deal for Cidara, FT Reports, Citing Sources
DJ
Ler
23 de jun. de 2025, 12:05 UTC
Cidara Shares Soar Premarket After Positive Influenza Trial Results
DJ
Ler
14 de nov. de 2025, 16:30 UTC
Merck Is Paying Up for Flu Biotech as M&A Spree Continues -- Barrons.com
DJ
Ler
14 de nov. de 2025, 13:19 UTC
This Biotech Stock Is Soaring 100%. Merck Is Buying It. -- Barrons.com
DJ
Ler
14 de nov. de 2025, 12:22 UTC
Pharma Sector Becoming Bidding Battlefield -- Market Talk
DJ
Ler
Variação de preço
By TipRanks
Previsão para 12 meses
Média 209.67 USD -4.8%
Máximo 221.5 USD
Mínimo 173 USD
Com base em 8 analistas de Wall Street que oferecem metas de preço de 12 meses para CIDARA THERAPEUTICS INC - Dist nos últimos 3 meses.
By TipRanks
Neutro
8 ratings
2
Comprar
6
Manter
0
Vender
Com base em 8 analistas que deram avaliações de ações para CIDARA THERAPEUTICS INC - Dist nos últimos 3 meses.
By Trading Central
Curto Prazo
Bearish Evidence
Recent bearish events outweigh bullish events.
Médio Prazo
Strong Bearish Evidence
All events are bearish.
Longo Prazo
Strong Bullish Evidence
All events are bullish.
$